Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
2023 · The Lancet · 219 citations
https://doi.org/10.1016/s0140-6736(23)00085-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
328
Citations
3
h-index
2
i10-index
Faith D Ottery is an academic researcher. The author has contributed to research in topics: Menopause: Health Impacts and Treatments & Estrogen and related hormone effects & Pharmacogenetics and Drug Metabolism. The author has an h-index of 3, co-authored 3 publications.
Click to start Chat